Literature DB >> 10311607

Measurement of health state utilities for economic appraisal.

G W Torrance.   

Abstract

Health status measurement for use in economic appraisal of health care programmes is reviewed in this paper, with particular emphasis on utility measurement. A framework for economic appraisal is presented displaying the various components that must be measured, and showing how the three forms of analysis (cost-effectiveness analysis, cost-benefit analysis and cost-utility analysis) relate to the framework and to each other. One of the components in the framework is health status; it can be measured using ad hoc numeric scales, willingness to pay/receive or health state utilities. The determination of health state utilities is reviewed covering the following issues: alternative sources of utilities, health state descriptions, multi-attribute utility approach, determination of appropriate subjects, utility aggregation, and accuracy. Three measurement techniques for health state utilities are described in detail: rating scale, standard gamble, and time trade-off. The use of these methods is described for both chronic and temporary health states and for both health states considered better than death and those considered worse than death.

Entities:  

Mesh:

Year:  1986        PMID: 10311607     DOI: 10.1016/0167-6296(86)90020-2

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  460 in total

1.  Outcomes research and community health information systems.

Authors:  C H Slater
Journal:  J Med Syst       Date:  1999-08       Impact factor: 4.460

2.  Patient preferences and utilities for 'off-time' outcomes in the treatment of Parkinson's disease.

Authors:  C S Palmer; J K Schmier; E Snyder; B Scott
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

3.  Reliability, validity and responsiveness of two multiattribute utility measures in patients with chronic obstructive pulmonary disease.

Authors:  K Stavem
Journal:  Qual Life Res       Date:  1999       Impact factor: 4.147

4.  Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

Authors:  X Badia; S Monserrat; M Roset; M Herdman
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

5.  The Assessment of Quality of Life (AQoL) instrument: a psychometric measure of health-related quality of life.

Authors:  G Hawthorne; J Richardson; R Osborne
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

6.  Culture, self-rated health and resource allocation decision-making.

Authors:  V L Wiseman
Journal:  Health Care Anal       Date:  1999

Review 7.  Willingness to pay and the valuation of programmes for the prevention and control of influenza.

Authors:  S Birch; A Gafni; B O'Brien
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 8.  Benefit valuation in economic evaluation of cancer therapies. A systematic review of the published literature.

Authors:  J Brown; M Sculpher
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

9.  The effect of individually assessed preference weights on the relationship between holistic utilities and nonpreference-based assessment.

Authors:  S J Jansen; A M Stiggelbout; M A Nooij; J Kievit
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 10.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.